Boundless Bio Funding & Investors
Los Angeles, CA
Boundless Bio, a San Diego based company backed by ARCH Venture Partners, is discovering and developing novel cancer therapeutics based on the role of extrachromosomal DNA (ecDNA) in driving tumorigenesis, resistance and recurrence.
boundlessbio.comTotal Amount Raised: $251,400,000
Boundless Bio Funding Rounds
Series C
$100,000,000
Series C Investors
Leaps by BayerRa Capital ManagementRedmile GroupSectoral Asset ManagementVertex Ventures HCGT Healthcare Capital PartnersFidelity InvestmentsSurveyor CapitalWellington ManagementArch Venture PartnersPiper Heartland Healthcare CapitalNextech InvestPFM Health SciencesAlexandria Venture InvestmentsCity Hill VenturesLogos CapitalSeries B
$105,000,000
Series B Investors
Nextech InvestRa Capital ManagementLogos CapitalSurveyor CapitalPFM Health SciencesWellington ManagementRedmile GroupFidelity InvestmentsArch Venture PartnersCity Hill VenturesAlexandria Venture InvestmentsGT Healthcare Capital PartnersBoxer CapitalVertex Ventures HCSeries A
$46,400,000
Series A Investors
Arch Venture PartnersCity Hill VenturesGT Healthcare Capital PartnersBoxer CapitalAlexandria Venture InvestmentsVertex Ventures
Funding info provided by Diffbot.